News
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...
(Reuters) -German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals ...
Bayer A.G. ( OTCPK:BAYZF) ( OTCPK:BAYRY) said that an advisory panel of the European Medicines Agency (EMA), endorsed the ...
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
Explore more
Some public libraries have yearbooks from the schools that used to serve their towns. The Hoyt Memorial Library in Kingston ...
19h
GlobalData on MSNBayer’s Eylea set for longer treatment intervals to challenge Roche’s VabysmoAn EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results